126 related articles for article (PubMed ID: 35353393)
41. Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination?
Puetz K; Bollschweiler E; Semrau R; Mönig SP; Hölscher AH; Drebber U
Histopathology; 2019 Apr; 74(5):731-743. PubMed ID: 30636069
[TBL] [Abstract][Full Text] [Related]
42. Significance of druggable targets (PD-L1, KRAS, BRAF, PIK3CA, MSI, and HPV) on curatively resected esophageal squamous cell carcinoma.
Lee HK; Kwon MJ; Ra YJ; Lee HS; Kim HS; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Min KW; Kang SY
Diagn Pathol; 2020 Oct; 15(1):126. PubMed ID: 33054840
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
[TBL] [Abstract][Full Text] [Related]
44. Residual Cancer Volume Predicts Clinical Outcome in Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy.
Nakao R; Konishi E; Fujiwara H; Otsuji E; Yokota I; Urata Y; Yanagisawa A
Int J Surg Pathol; 2019 Oct; 27(7):713-721. PubMed ID: 31203677
[No Abstract] [Full Text] [Related]
45. Overexpression of SRC-3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness.
Xu FP; Liu YH; Luo XL; Zhang F; Zhou HY; Ge Y; Liu C; Chen J; Luo DL; Yan LX; Mei P; Xu J; Zhuang HG
Cancer Med; 2016 Dec; 5(12):3500-3511. PubMed ID: 27781415
[TBL] [Abstract][Full Text] [Related]
46. [Prognostic influence of preoperative Nutritional Risk Screening -2002 (NRS-2002) score for patients with thoracic esophageal squamous cell carcinoma receiving surgery].
Sun HJ; Guo XW; Ji SJ; Zhou SB; Gu L
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):917-921. PubMed ID: 30605983
[No Abstract] [Full Text] [Related]
47. Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma.
Wu H; Yu Y; Zheng Q; Liu T; Wu Y; Wang Z; Zheng H; Liu L; Li J
Radiat Oncol; 2021 Oct; 16(1):207. PubMed ID: 34717670
[TBL] [Abstract][Full Text] [Related]
48. Combined prognostic value of the cancer stem cell markers CD47 and CD133 in esophageal squamous cell carcinoma.
Wang JH; Huang ST; Zhang L; Liu ZG; Liang RX; Jiang SW; Jiang YN; Yu XJ; Jiang YC; Li XZ; Zhang PF; Wen ZS; Zheng M
Cancer Med; 2019 Mar; 8(3):1315-1325. PubMed ID: 30741466
[TBL] [Abstract][Full Text] [Related]
49. YAP1 amplification as a prognostic factor of definitive chemoradiotherapy in nonsurgical esophageal squamous cell carcinoma.
Dai H; Shao YW; Tong X; Wu X; Pang J; Feng A; Yang Z
Cancer Med; 2020 Mar; 9(5):1628-1637. PubMed ID: 31851786
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of the pN classification supplemented by vascular invasion for esophageal squamous cell carcinoma.
Zhu CM; Ling YH; Xi SY; Luo RZ; Chen JW; Yun JP; Xie D; Cai MY
PLoS One; 2014; 9(4):e96129. PubMed ID: 24763284
[TBL] [Abstract][Full Text] [Related]
51. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
[TBL] [Abstract][Full Text] [Related]
52. PD-L1 expression on tumor cells associated with favorable prognosis in surgically resected esophageal squamous cell carcinoma.
Guo W; Zhang F; Shao F; Wang P; Li Z; Yang X; He Z; Shi S; Gao Y; He J
Hum Pathol; 2019 Feb; 84():291-298. PubMed ID: 30296523
[TBL] [Abstract][Full Text] [Related]
53. Keratin 17 activates AKT signalling and induces epithelial-mesenchymal transition in oesophageal squamous cell carcinoma.
Liu Z; Yu S; Ye S; Shen Z; Gao L; Han Z; Zhang P; Luo F; Chen S; Kang M
J Proteomics; 2020 Jan; 211():103557. PubMed ID: 31669361
[TBL] [Abstract][Full Text] [Related]
54. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
55. Distribution and prognostic impact of M1 macrophage on esophageal squamous cell carcinoma.
Jiang CH; Liang WH; Li FP; Xie YF; Yuan X; Zhang HJ; Li M; Li JF; Zhang AZ; Yang L; Liu CX; Pang LJ; Li F; Hu JM
Carcinogenesis; 2021 Apr; 42(4):537-545. PubMed ID: 33269791
[TBL] [Abstract][Full Text] [Related]
56. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy.
Chen YF; Li Q; Chen DT; Pan JH; Chen YH; Wen ZS; Zeng WA
Cancer Biomark; 2016 Jun; 17(1):89-96. PubMed ID: 27314297
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of programmed death-1 and programmed death-ligand 1 expression in patients with esophageal squamous cell carcinoma.
Chen K; Cheng G; Zhang F; Zhang N; Li D; Jin J; Wu J; Ying L; Mao W; Su D
Oncotarget; 2016 May; 7(21):30772-80. PubMed ID: 27120796
[TBL] [Abstract][Full Text] [Related]
58. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma.
Shi ZZ; Wang WJ; Chen YX; Fan ZW; Xie XF; Yang LY; Chang C; Cai Y; Hao JJ; Wang MR; Bai J
Cell Death Dis; 2020 Jul; 11(7):597. PubMed ID: 32732965
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
Li KK; Mao CY; Zhang JG; Ma Q; Wang YJ; Liu XH; Bao T; Guo W
Thorac Cancer; 2019 Nov; 10(11):2071-2080. PubMed ID: 31496055
[TBL] [Abstract][Full Text] [Related]
60. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]